We are live on ! Find out more
MLICM

Metropolitan Life Insurance Company (MetLife) Portfolio holdings

AUM $357M
1-Year Est. Return 13.97%
This Fund
S&P 500
This Quarter Est. Return
+0.3%
1 Year Est. Return
+13.97%
3 Year Est. Return
+50.79%
5 Year Est. Return
+74.78%
10 Year Est. Return
+368.42%
AUM
$13.9B
AUM Growth
-$512M
Cap. Flow
-$427M
Cap. Flow %
-3.07%
Top 10 Hldgs %
13.98%
Holding
2,837
New
70
Increased
591
Reduced
1,041
Closed
180

Sector Composition

Rank Sector Weight
1 Technology 13.38%
2 Financials 12.91%
3 Healthcare 12.18%
4 Energy 11.84%
5 Industrials 10.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMKR icon
1651
Amkor Technology
AMKR
$14.3B
$559K ﹤0.01%
66,472
EGBN icon
1652
Eagle Bancorp
EGBN
$877M
$559K ﹤0.01%
17,566
-1,247
-7% -$41.7K
IRDM icon
1653
Iridium Communications
IRDM
$5.27B
$558K ﹤0.01%
63,093
LMNX
1654
DELISTED
Luminex Corp
LMNX
$558K ﹤0.01%
28,602
-2,258
-7% -$41.3K
AMAG
1655
DELISTED
AMAG Pharmaceuticals
AMAG
$556K ﹤0.01%
17,421
-1,896
-10% -$40.4K
CHCO icon
1656
City Holding Co
CHCO
$2.08B
$555K ﹤0.01%
13,171
MDXG icon
1657
MiMedx Group
MDXG
$624M
$555K ﹤0.01%
77,798
RSTI
1658
DELISTED
Rofin-Sinar Technologies Inc
RSTI
$553K ﹤0.01%
23,978
BMI icon
1659
Badger Meter
BMI
$3.91B
$551K ﹤0.01%
21,848
HAFC icon
1660
Hanmi Financial
HAFC
$956M
$551K ﹤0.01%
27,348
-2
-0% -$42
LE icon
1661
Lands' End
LE
$391M
$547K ﹤0.01%
13,306
PMC
1662
DELISTED
PharMerica Corporation
PMC
$547K ﹤0.01%
22,381
-3,303
-13% -$87.6K
BDSI
1663
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$547K ﹤0.01%
31,986
-9,381
-23% -$136K
LVLT
1664
DELISTED
Level 3 Communications Inc
LVLT
$545K ﹤0.01%
11,914
-79
-0.7% -$3.51K
CQB
1665
DELISTED
CHIQUITA BRANDS INTL (NEW)
CQB
$544K ﹤0.01%
38,313
ELGX
1666
DELISTED
Endologix Inc
ELGX
$542K ﹤0.01%
5,112
CPLA
1667
DELISTED
Capella Education Company
CPLA
$542K ﹤0.01%
8,653
-148
-2% -$9.21K
NFBK
1668
DELISTED
Northfield Bancorp
NFBK
$541K ﹤0.01%
39,751
-6,738
-14% -$88.5K
SGMO
1669
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$541K ﹤0.01%
50,164
-6,485
-11% -$84.7K
CBB
1670
DELISTED
Cincinnati Bell Inc.
CBB
$541K ﹤0.01%
32,079
+6,557
+26% +$123K
SGNT
1671
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
$538K ﹤0.01%
17,285
CAMP
1672
DELISTED
CalAmp Corp.
CAMP
$536K ﹤0.01%
1,322
BCRX icon
1673
BioCryst Pharmaceuticals
BCRX
$2.51B
$535K ﹤0.01%
54,718
ININ
1674
DELISTED
Interactive Intelligence Group, inc.
ININ
$534K ﹤0.01%
12,782
NXGN
1675
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
$533K ﹤0.01%
38,708

Similar funds

Metropolitan Life Insurance Company (MetLife)'s Q3 2014 Portfolio in Review

As of Q3 2014, Metropolitan Life Insurance Company (MetLife) held 2,837 positions worth $13.9B, down 3.6% from $14.4B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Metropolitan Life Insurance Company (MetLife) withdrew a net $427M in Q3 2014, closing 180 positions and reducing 1,041 holdings. Its most notable exit was Accenture, an estimated $31.6M position sold in full.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Metropolitan Life Insurance Company (MetLife) opened a new position in Monsanto Co worth $35.2M.

  • Metropolitan Life Insurance Company (MetLife)'s largest Q3 2014 buy was Monsanto Co: 313,199 shares worth $35.2M.
  • Metropolitan Life Insurance Company (MetLife) added most to Microsoft in Q3 2014, an estimated $14M increase.
  • Metropolitan Life Insurance Company (MetLife)'s biggest Q3 2014 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $22.5M.
  • Metropolitan Life Insurance Company (MetLife) fully exited Accenture in Q3 2014, selling an estimated $31.6M.
  • Metropolitan Life Insurance Company (MetLife)'s ten largest holdings make up 14% of its $13.9B portfolio in Q3 2014.
  • Metropolitan Life Insurance Company (MetLife) opened 70 new positions and closed 180 in Q3 2014.
  • Metropolitan Life Insurance Company (MetLife)'s portfolio value fell 3.6% quarter-over-quarter to $13.9B.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q3 2014, filed 10 Nov 2014.